EVRYSDI 0.75 mg/ml, powder for oral solution bottle, 1 ml
Active ingredients: Risdiplam
Commercialized according to BDPMDispensing in France: Prescription only
Powder for oral solutionbottle, 1 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- EVRYSDI 0,75 mg/mL, poudre pour solution buvable
- Pharmaceutical form
- poudre pour solution buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre jaune(brun) + 1 adaptateur pour flacon + 2 seringues orales ambrées graduées réutilisables de 1 mL + 2 seringue orales ambrées graduées réutilisables de 6 mL + 1 seringue orale ambrée graduée réutilisable de 12 mL
- Marketing authorisation holder
- ROCHE REGISTRATION (ALLEMAGNE)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 28 Jun 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68009899CIP73022938CIP133400930229385Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RISDIPLAMpoudre | 0,75 mg · 1 mL de solution reconstituée | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.